Amgen Technology (Ireland) Unlimited Company
SpainAll drugs from this manufacturer
-
It is used to treat adults and children with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), diseases that affect the blood system and, in the case of aHUS, also the kidney.
Dosage form: solution for infusion, concentrate
Active substance Dosage eculizumab 300 mg -
It is used to treat adult patients with various types of cancer, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 100 mg -
What type of cancer is MVASI prescribed for?": "It is used to treat adults with advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.", "How should MVASI be administered?": "It is administered via intravenous infusion (drip into the veins) performed by a doctor or nurse. The dose depends on the patient's weight and is applied once every 2 or 3 weeks.", "When should this medicine not be used?": "It should not be used if you are allergic to bevacizumab or its components, if you are allergic to products derived from Chinese hamster ovary cells or other similar antibodies, or if you are pregnant.", "What side effects can MVASI cause?": "It may cause frequent side effects such as high blood pressure, fatigue, diarrhea, nausea, vomiting, abdominal pain, decreased blood cell counts, and a tingling sensation. There are also risks of serious side effects such as intestinal perforation, bleeding, healing problems, blood clots (thrombi), and allergic reactions.", "Are there interactions with other medicines?": "You must inform your doctor if you are using other drugs, especially if you are taking sunitinib maleate, as the combination can cause serious effects. It is also important to inform them if you are receiving platinum-based or taxane-based treatments, or if you have recently received radiotherapy.", "What precautions should I take regarding my dental health?": "You must inform your doctor and dentist if you have pain, swelling, or sores in your mouth, or if you require invasive dental treatment, as the medicine can affect the health of the jawbone.", "What should I do if I am pregnant or planning to become pregnant?": "You must not use this medicine if you are pregnant, as it can harm the fetus. You must use contraceptive methods during treatment and for up to 6 months after the last dose. You should also not breastfeed during treatment or for up to 6 months after the last dose."}
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 400 mg -
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Dosage form: solution for infusion, concentrate
Active substance Dosage ustekinumab 90 mg -
It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection
Active substance Dosage ustekinumab 45 mg -
It is used in adults to treat inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases in adults, specifically plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 90 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection
Active substance Dosage ustekinumab 90 mg